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ABSTRACT
Hansen’s disease is probably the human disease that causes more damage. The aim 
of this study was to investigate the association between the occurrence of the association 
of grade 1 and 2 physical disabilities in Hansen’s disease, as well as implications of joint 
analysis and strength of association with independent demographic and clinical variables. 
This is a quantitative, descriptive, retrospective, population-based and documentary study 
developed from 2009 to 2014 in a Hansen’s disease reference center in Joao Pessoa, PB. 
It involved 414 medical records, the diagnosis and discharge data on socio-demographic, 
clinical and simplified neurological evaluation variables. Data were analyzed using descriptive 
(absolute frequency and percentage) and inferential (Chi-Square and Prevalence Ratio (PR) 
statistics techniques. Both in the diagnosis and discharge, low education level, multibacillary 
classification and presence of affected nerves were statistically associated to the development 
of disabilities (p <0.05). The gender showed association only at discharge (p <0.05). Male 
gender, low education level, multibacillary classification and presence of affected nerves 
were identified as factors associated with the development of disabilities, and the  individuals 
were more likely to develop disabilities at discharge. There is a need for development of 
surveillance actions for the population group identified for the detection and early treatment 
of the disease. Higher chances of developing disabilities in the discharge period makes the 
promotion of guidelines that standardize the care of these individuals imperative.
KEYWORDS: Hansen’s disease. Risk factors. Prevention and control. Secondary care. 
INTRODUCTION
Hansen’s disease is probably the human disease that causes more damage. 
Estimates suggest the existence of 2 to 3 million people in the world living with 
sequels resulting from this disease1. In Brazil, it presents itself as a public health 
problem, in view of the large number of notifications of new cases diagnosed with 
stage 2 disabilities (S2D)2.
The S2D occur when there are deformities seen in the body parts affected by 
Hansen’s disease, as claws, bone reabsorption, muscle atrophy, contractures and 
wounds, which can be observed in the hands and feet; lagophthalmos, ectropion 
and entropion, trichiasis, corneal opacity and iridocyclitis in the eye3. In addition 
to limiting the performance in activities and restrict the social participation, these 
deformities can also predispose the stigma reflecting psychological, economic, and 
social losses4.
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Brazil is the second in the world scene in number of 
notifications of new cases with S2D, registering 1,752 cases 
in 2015. Despite the high indices recorded, this indicator 
is showing a declining trend over the years, observing a 
decline of 29% in the last 10 years (2005-2015)2,5.
In order to further reduce the burden of Hansen’s disease 
in Brazil and in the world, the current strategy for combating 
the disease proposes as one of its goals for the year of 
2020, the reduction in the rate of individuals with S2D to 
<1 case per million inhabitants, which corresponded to 2.1 
cases per million inhabitants in 2015. For both, actions are 
proposed to strengthen the awareness of individuals about 
the disease, early detection through the active search of 
cases, immediate commencement/adherence to treatment 
and the improvement of prevention and management of 
disabilities2,6.
Although several factors associated with the development 
of disabilities are addressed in scientific articles, it is clear 
that studying the magnitude of each factor, alone or 
associated, the chances of an individual illness, or even 
worsen, empowers managers, health professionals and 
researchers in the implementation of strategies directed to 
health care.
Thus, it is essential to strengthen interventions that 
prevent illness and the worsening of disabilities, bearing in 
mind that despite all diagnostic and therapeutic procedures 
performed in our country, weaknesses in the health services 
that favor the disease development and problems regarding 
their early detection are still found.
There are several factors that affect the control of 
Hansen’s disease, such as socioeconomic, emotional, 
environmental and biological factors7 and knowledge about 
these, at local and tate levels, are essential to identify and 
direct attention to the health of vulnerable groups.
Considering that research involving this context 
are still scarce in Brazil, it is expected that this study 
can subsidize managers and health professionals in the 
planning of actions directed to individuals who have a 
chance of developing disabilities, prioritizing actions for 
monitoring and improvement of the plans that subsidize 
their prevention. For both, the objective of this study was 
to investigate the association between the occurrence of 
grade 1 and 2 physical disabilities in Hansen’s disease, the 
implications of joint analysis and the strength of association 
with independent demographic and clinical variables.
MATERIALS AND METHODS
This is a descriptive, retrospective, population-based 
and documentary source study, quantitatively conducted 
between 2009 and 2014 with records of patients with 
diagnosis of Hansen’s disease treated at a reference center 
specialized in the treatment of disease in the city of Joao 
Pessoa, Paraiba, Brazil.
This service has been a reference for health dermatology 
care since the end of the 1980s, attending approximately 150 
cases of leprosy patients coming from several municipalities 
of the State. Due to the weaknesses of basic care, the service 
performs both routine diagnosis and receives cases of 
difficult diagnosis and management, carried out by means 
of spontaneous demand and through referrals. The care of 
patients is performed by a multiprofessional team composed 
of medical doctors, nurses, physiotherapists, occupational 
therapists, psychologists, nutritionists and dentists.
The study population consisted of 485 patients in 
the metropolitan region of Joao Pessoa, involving 12 
municipalities, namely: Alhandra, Bayeux, Caapora, 
Cabedelo, Conde, Cruz do Espirito Santo, Joao Pessoa, 
Lucena, Pedras de Fogo, Pitimbu, Rio Tinto and Santa Rita.
As inclusion criteria, the following were established: 
medical records of patients in the metropolitan region of 
Joao Pessoa, who started and finished the treatment for 
Hansen’s disease in the reference center and had filled the 
simplified evaluation of neural functions and complications 
both in diagnosis and in the rate of cure. Exclusion criteria: 
medical records of patients with cognitive impairment 
(n=4), due to inability to perform the neurological simplified 
assessment; records with incomplete information (n=61); 
and records of patients who did not undergo the treatment 
according to the Ministry of Health (MoH) recommended 
time (n=6) (paucibacillary Hansen’s disease - 6 doses at 
up to 9 months and multibacillary cases - 12 doses in up to 
18 months). In this way, the study population consisted of 
414 records of patients.
Data were collected from January to April 2016 through 
a structured instrument from the records of the patients, 
from which demographic variables were extracted (gender, 
age, educational level and occupation) at admission, as 
well as clinical variables (operational classification - 
paucibacillary or multibacillary) of the notification form.
The instrument was also composed of information 
related to the time of diagnosis and the rate of cure from the 
simplified evaluation of neural functions and complications. 
The use of this connector is recommended by MoH and is 
based on a neurological evaluation to identify the severity 
of the lesions in the eyes, nose, hands and feet3, being an 
integral part of the assessment made in the service.
Regarding the eyes, information was collected 
regarding the presence or absence of trichiasis, ectropion, 
lagophthalmos, sensitivity of the cornea, corneal opacity and 
visual acuity. In the nose, items related to dryness, wound 
and perforation of the septum were investigated. To record 
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information about hands and feet, data on the presence or 
absence of hypoesthesia, ulcer, claws, foot or hand fall and 
bone resorption were used. The number of affected nerves 
and their classification in ulnar, radial, medial, common 
fibular and posterior tibial was also recorded.
In each connector, the maximum stage of physical 
disabilities (SPD) ranging from 0 to 2 was considered. 
Stage 0 is used when there is no damage present in the eyes, 
hands and feet, stage 1 corresponds to a decrease or loss of 
sensitivity and stage 2 refers to the presence of deformities, 
visibly due to Hansen’s disease8.
It is noteworthy that in 2016 a technical manual-
operational entitled “Guidelines for surveillance, attention 
and elimination of Hansen’s disease as a public health 
problem” as release, and it contained modified criteria for 
evaluation of the SPD including the muscular strength as a 
criterion3. However, as the study was carried out from 2009 
to 2014, this amendment was not considered.
Procedures for data collection included purchase 
requisition from the list of records from customers who were 
seen in the study period in the sector of epidemiological 
surveillance of the center of reference for subsequent 
request of these data at the Medical Files Service and 
Statistics, responsible for organizing and providing the 
records. Then, there was the information completion on 
the instrument.
The obtained data were coded for tabulating in 
Microbland Excel, and then exported and analyzed by the 
Statistical Package for the Social Sciences (SPSS) version 
20.0 using descriptive statistical techniques (absolute 
frequency and percentage) and inferential tests (chi-square, 
prevalence ratios -PR and Fisher’s exact test).
The first two tests provided an analysis about the 
relationship and association estimative between exposure 
to factors (demographic and clinical variables) and the 
outcome (the development of disability). It should be 
emphasized that the significance level used was 5% 
(p<0.05).
For performing the association tests, data regarding the 
level of education and the clinical form were categorized, 
so that individuals with basic education (less than eight 
years of study) were classified as low level of education 
and those with high school and college (more than eight 
years of study), as moderate/high. 
In the research process the ethical observances 
contemplated in the guidelines and regulatory standards 
for research involving human subjects - Resolution 466/12 
of the Brazilian National Health Council9 were adopted 
especially with regard to the secrecy and confidentiality 
of data. The project was approved by the Research 
Ethics Committee at the Health Sciences Center of the 
Universidade Federal da Paraiba, under the protocol 443/14, 
CAAE 34284414.3.0000.5188.
RESULTS
Among the participants involved in the study, there 
was a male predominance (58.7%), aged 31 to 45 years 
(27.8%), basic education as educational level (53.6%) and 
classification multibacillary (60.6%).
In Table 1, it can be observed that, at the time of diagnosis, 
the variables educational level and operational classification 
are statistically associated with the development of physical 
disabilities (p<0.05). It is emphasized that multibacillary 
individuals are twice as likely to develop sequelae as 
paucibacillary individuals.
Table 2 represents the time of discharge, in addition to 
the aforementioned variables, gender was also significantly 
associated with the occurrence of physical disabilities 
(p<0.05). All the variables that showed significant 
association with the disabilities were more likely to develop 
them at discharge compared to the time of diagnosis. 
With respect to the types of nerves, both in diagnosis 
and in the rate of cure, it is possible to observe that the 
impairment of the ulnar, radial, median, common peroneal 
and posterior tibial nerves were significantly associated 
with disability (p<0.05) (Table 3). 
DISCUSSION
The emergence of disabilities in patients diagnosed with 
Hansen’s disease indicates the presence of some gaps in the 
disease control, among them the social aspects of individuals. 
The analysis of this study found that men, low educational 
level and operational classification multibacillary Hansen’s 
disease are related to the development of disabilities (1 or 
2). Have affected nerves, either at diagnosis or at the time 
the rate of cure was recorded, also configured predisposition 
to sequels settlement.
For many pathologies, gender has been implicated as a 
factor associated with the occurrence of morbidities and their 
worsening. In this study, the male gender was associated 
with the development disabilities when compared to female, 
both at the time of diagnosis and at the establishment of 
the rate of cure. It should be emphasized, however, that 
the statistical power have configured significant (p=0.039) 
only in the discharge period, with probability 30% higher 
at this time.
A study in the micro-region of Diamantina, Minas 
Gerais State, evidenced, in the male population, increased 
rates of S2D diagnosis (32.4%), highlighting the late 
discovery of the disease in these individuals. The authors 
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PR** (IC. 95%)Stage (1 or 2) Stage 0
n % n % N %
Pacient’s gender     
Male 243 100 103 42,4 140 57,6
Female 171 100 65 38,0 106 62,0 1,115 (0,876 - 1,419)
Total 414 100 168 40,6 246 59,4
Education level (*)     
Low 222 100 106 47,7 116 52,3
Moderate/High 192 100 62 32,3 130 67,7 1,479 (1,155 - 1,892)
Total 414 100 168 40,6 246 59,4
Operational Classification (*)     
Paucibacillary 163 100 36 22,1 127 77,9
Multibacillary 251 100 132 52,6 119 47,4 2,381 (1,744 - 3,251)
Total 414 100 168 40,6 246 59,4
(*) Significant association ≤ 0,05.  (**) PR = Prevalence Ratio. Source: Research data, 2016.





PR** (IC. 95%)Stage (1 or 2)           Stage 0
n % N % n %
Pacient’s gender (*)    
Male 243 100 101 41,6 142 58,4
Female 171 100 54 31,6 117 68,4 1,316 (1,009 - 1,718)
Total 414 100 155 37,4 259 62,6
Education level (*)    
Low 222 100 105 47,3 117 52,7
Moderate/High 192 100 50 26 142 74 1,816 (1,378 - 2,393)
Total 414 100 155 37,4 259 62,6
Operational Classification (*)    
Paucibacillary 163 100 28 17,2 135 82,8
Multibacillary 251 100 127 50,6 124 49,4 2,946 (2,058 - 4,216)
Total 414 100 155 37,4 259 62,6
(*) Significant association ≤ 0,05. (**) PR = Prevalence Ratio. Source: Research data, 2016.
emphasize that, generally, men seek health services only for 
the treatment of a disease, while women, by virtue of the 
aesthetic aspects and the various programs for their health, 
pay more attention10.
The low educational level, which presented probability 
40% higher of developing disabilities at the time of diagnosis 
and 80% in the discharge period, was also an associated factor 
found by other authors10-12, corroborating the findings in 
individuals who have a lower educational level. The degree 
of instruction is a determinant factor for the development 
of SPD, since the knowledge about the disease and the 
understanding of the guidelines, preventive and therapeutic 
measures influence the ability for self-care13, which is 
fundamental to the achievement of preventive actions.
Attention should be paid to the level of education of 
the patients in order to promote the understanding about 
health education. Through it, individuals become jointly 
responsible for their treatment, being able to identify 
Rev Inst Med Trop São Paulo. 2018;60:e27
Factors associated with the development of physical disabilities in Hansen’s disease
Page 5 of 7
and treat possible alterations in body parts, in addition to 
performing self-care activities in their daily lives14.
Analyzing the clinical aspects, the individuals classified 
as multibacillary patients presented probability 2 times higher 
for the incapacities settlement, both at the time of diagnosis 
(PR=2.381) and high (PR=2.946). These findings were 
similar to the ones of a prevalence study after drug therapy 
of Hansen’s disease discharge15, and they found a chance 9 
times greater of these individuals to develop sequels when 
compared with paucibacillary Hansen’s disease13.
The patients of multibacillary classification, the most 
important group with ability to infect non treated individuals, 
presents high bacillary load and are consequently more 
likely to developing physical disabilities due to illness. 
When the diagnosis is late, the situation becomes worse 
due to a higher chance of transmission and the presence of 
neural complications in the patients16,17.
It is noteworthy that the diagnosis and immediate 
treatment are the more effective measures to reduce the 
occurrence of sequels of Hansen’s disease and until some 
method of stopping its transmission of the disease arises, 
individuals will continue to develop sequels18.
In the analysis of nervous impairment, the presence of 
any affected nerve (ulnar, median, radial, common peroneal 
and posterior tibial nerves) is associated with a 2 times 
greater possibility to develop any SPD 2 excepting the radial 
and common peroneal, which showed lower values at the 
time of diagnosis (PR=1.844 and PR=1.994).
One of the justifications for the radial nerve to have a 
lower probability at the time of the diagnostic evaluation is 
that it has a more protected location which is only reached 
after the impairment of the ulnar and median nerves that has 
a threefold chance of evolving to paralysis. When achieved, 
the individual is unable to extend the wrist and fingers with 
the sagging hand. In lesions of the ulnar and median nerves, 
several abnormalities such as the rise of claws in response to 
weakness and/or paralysis of the muscles of the hand, as well 
as the loss of the ability of the thumb opposition can occur8.
In the case of the common fibular nerve, the deformity 
in horse’s foot only happens when the two branches of the 
nerve (shallow and deep) are injured, making the ankle disk 
in this position, requiring, therefore, a greater impairment 
until the appearance of the lesion. Even in the lower limbs, 
feet can also acquire the posture of claw due to lesions in 
the posterior tibial nerve and consequent impairment of all 
intrinsic foot muscles8.
A study involving the analysis of factors associated with 
disability, diagnosis showed that individuals who had two or 
more affected nerve trunks were also 2 times more likely to 
develop some sequel12. Corroborating our findings, Ribeiro 








test PR** (IC. 95%)
 Stage – (1 ou 2) Grau – 0 Sig. p-valor
n % n % N %  
Ulnar     p(1)=0,000*
Diagnosis 118 100 77 65,3 41 34,7  2,123 (1,711 - 2,634)
Discharge 84 100 55 65,5 29 34,5  2,161 (1,724 - 2,707)
Radial     p(1)=0,000*
Diagnosis 60 100 40 66,7 20 33,3  1,844 (1,470 - 2,312)
Discharge 34 100 24 70,6 10 29,4  2,048 (1,583 - 2,649)
Median     p(1)=0,000*
Diagnosis 95 100 70 73,7 25 26,3  2,398 (1,956 - 2,941)
Discharge 34 100 24 70,6 10 29,4  2,048 (1,583 - 2,649)
Common Fibular     p(1)=0,000*
Diagnosis 83 100 56 67,5 27 32,5  1,994 (1,613 - 2,465)
Discharge 56 100 44 78,6 12 21,4  2,534 (2,062 - 3,115)
Tibial Posterior     p(1)=0,000*
Diagnosis 102 100 71 69,6 31 30,4  2,239 (1,816 - 2,760)
Discharge 80 100 62 77,5 18 22,5  2,783 (2,258 - 3,431)
(*) Significant association ≤ 0,05. (**) PR = Prevalence Ratio. Source: Research data, 2016.
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and Lana10 identified the presence of damaged nerves at 
the time of diagnosis as factors related to the occurrence 
of S2D diagnosis. If the individual has already nervous 
impairment at the time of diagnosis, two possibilities can 
explain it: either the discovery is late, or the clinical form is 
quite aggressively. Both premises corroborate to identify a 
framework of rapid deterioration and consequent deformity.
It is important to emphasize that, at the time of 
discharge, all demographic and clinical variables had a 
greater probability of developing sequels in this situation. 
Assuming the justification of this result is difficult due to the 
various intrinsic factors related to illness, monitoring and 
aggravation of cases. However, it is possible and urgent to 
raise questions about why patients who underwent treatment 
and were discharged as cured have a higher chance of 
developing disabilities. Among the assumptions that may 
be involved in this context, it is possible to cite the absence 
of self-care activities, the development of resistance to drug 
treatment and the presence of exacerbated inflammatory 
response to an already existing damage.
MoH recommends that all individuals are oriented to 
return after discharge due to healing, according to their 
needs, and that all information provided to patients in 
treatment is extended to the post-discharge period, mainly 
in cases that already have some incapacity, in view of the 
need for follow-up of the practices of self-adaptation of 
footwear, treating wounds and surgical rehabilitation3.
Regarding the research scenario, patients are followed-
up while receiving MDT doses, after which the care is 
discontinued. There is no communication between the 
referral service, secondary care, and family health units, 
primary care, nor a health care network established for the 
care of these individuals.
Surveys reveal weaknesses in continuity of assistance 
for patients in this period, due to fragmentation of care that 
compromises the quality of the treatment. Among them, 
the lack of standardization of this monitoring, which is 
targeted primarily for the treatment of the reactional states, 
and hinders the understanding of the clinical situation of 
affected individuals15,19. This fragility in care was also 
observed during treatment, in view of the worsening of 
patients’ neural function.
A study involving the period after the end of the 
multidrug therapy reveals that 60.9% of the patients had 
some degree of physical incapacity and that 24.9% had 
social restriction after an average of 7.5 years of treatment20. 
In another study, conducted in a hyperendemic area of 
Northern Brazil, it was found that the functional limitation 
presented by patients in the post-discharge period reflected 
considerably in the accomplishment of activities and social 
participation21.
Taking into account the increased likelihood of 
individuals in the post-discharge period that develop 
permanent sequels, it is necessary to design policies for 
the creation of a network of health attention seeking a 
regular, continuous and integral assistance to these patients, 
with the purpose of preventing physical disabilities and 
detecting previously reactional states and situations of 
disease recurrence. 
The present study identified as factors associated 
with the onset of physical disabilities: male gender, low 
education, operational classification multibacillary and 
presence of affected nerves. These findings point to the 
need of a follow-up of follow these groups of individuals.
Another result that deserves attention is the increased 
possibility of patients to develop sequels in the post-
discharge period of drug treatment, indicating the need 
to promote the guidelines that standardize the care during 
this period.
Considering that, as long as the Hansen’s disease is 
transmitted, there will be disabilities, it is important to 
sensitize and empower the multiprofessional healthcare 
team to adopt as routine the active search for patients with 
the purpose to diagnose and provide adequate treatment to 
the new cases, and to maintain surveillance of disability in 
already treated cases.
Although the spatial determination of the study has 
been about the same, expanding its methodological scope 
to other regions of the federation is of great importance, 
aiming to streamline the process of knowledge and compare 
data with the results found herewith. The inquiries scored 
in this study are subject to further research with the aim of 
expanding the pertinent knowledge of disability.
AUTHORS’ CONTRIBUTIONS
Emanuelle Malzac Freire de Santana: project design, 
data collection and analysis, article writing; Karen Krystine 
Gonçalves de Brito: project design, data analysis, article 
writing, critical review; Ester Missias Vilaverde Antas: 
critical review; Jordana de Almeida Nogueira, Oriana Deyze 
Correia Paiva Leadebal, Mirian Alves da Silva and Marta 
Mirian Lopes Costa: critical review and final approval; 
Maria Júlia Guimarães Oliveira Soares: guidance and 
collaboration from project design to final approval.
REFERENCES
 1.  Pinheiro MG, Silva SY, Silva FS, Ataide CA, Lima IB, Simpson 
CA. Conhecimento sobre prevenção de incapacidades em um 
grupo de autocuidado em hanseníase. REME Rev Min Enferm. 
2014;18:895-900.
Rev Inst Med Trop São Paulo. 2018;60:e27
Factors associated with the development of physical disabilities in Hansen’s disease
Page 7 of 7
 2.  World Health Organization. Global leprosy update, 2015: time 
for action, accountability and inclusion. Wkly Epidemiol Rep. 
2016;35:405-20.
 3.  Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. 
Departamento de Vigilância das Doenças Transmissíveis. 
Diretrizes para vigilância, atenção e eliminação da hanseníase 
como problema de saúde pública. Brasília: Ministério da 
Saúde; 2016. [cited 2018 May 2]. Available from: http://
portalarquivos2.saude.gov.br/images/pdf/2016/fevereiro/04/
diretrizes-eliminacao-hanseniase-4fev16-web.pdf 
 4.  van Brakel WH, Sihombing B, Djarir H, Beise K, Kusumawardhani 
L, Yulihane R, et al. Disability in people affected by leprosy: 
the role of impairment, activity, social participation, stigma 
and discrimination. Glob Health Action. 2012;5:18394. 
 5.  World Health Organization. Global leprosy situation. Wkly 
Epidemiol Rep. 2006;32:309-16
 6.  World Health Organization. Global leprosy strategy 2016–2020: 
accelerating towards a leprosy-free world. Geneva: WHO; 
2016. [cited 2018 May 2]. Available from: http://apps.searo.
who.int/PDS_DOCS/B5233.pdf?ua=1
 7.  Chaptini C, Marshman G. Leprosy: a review on elimination, 
reducing the disease burden, and future research. Lepr Rev. 
2015;86:307-15. 
 8.  Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. 
Departamento de Vigilância Epidemiológica. Manual de 
prevenção de incapacidades. Brasília: Ministério da Saúde; 
2008. [cited 2018 May 2]. Available from: http://bvsms.saude.
gov.br/bvs/publicacoes/manual_prevencao_incapacidades.pdf
 9.  Brasil. Ministério da Saúde. Conselho Nacional de Saúde. 
Resolução Nº 466, de 12 de dezembro de 2012. [cited 2018 
May 2]. Available from: http://bvsms.saude.gov.br/bvs/
saudelegis/cns/2013/res0466_12_12_2012.html
 10.  Ribeiro GC, Lana FC. Incapacidades físicas em hanseníase: 
caracterização, fatores relacionados e evolução. Cogitare 
Enferm. 2015;20:496-503.
 11.  Pieri FM, Ramos AC, Crispim JA, Pitiá AC, Rodrigues LB, 
Silveira TR, et al. Fatores associados às incapacidades em 
pacientes diagnosticados de hanseníase: um estudo transversal. 
2012;37:22-30. 
 12.  Monteiro LD, Martins-Melo FR, Brito AL, Alencar CH, 
Heukelbach J. Physical disabilities at diagnosis of leprosy in 
a hyperendemic area of Brazil: trends and associated factors. 
Lepr Rev. 2015;86:240-50. 
 13.  Ribeiro Júnior AF, Vieira MA, Caldeira AP. Perfil epidemiológico 
da hanseníase em uma cidade endêmica no Norte de Minas 
Gerais. Rev Bras Clin Med. 2012;10:272-7. 
 14.  Duarte LM, Simpson CA, Silva TM, Moura IB, Isoldi DM. Self-
care actions of people with leprosy. J Nurs UFPE On Line. 
2014;8:2816-22. 
 15.  Monteiro LD, Alencar CH, Barbosa JC, Braga KP, Castro MD, 
Heukelbach J. Incapacidades físicas em pessoas acometidas 
pela hanseníase no período pós-alta da poliquimioterapia 
em um município no Norte do Brasil. Cad Saude Publica. 
2013;29:909-20. 
 16.  Araújo e Araújo AE, Aquino DM, Goulart IM, Pereira SR, 
Figueiredo IA, Serra HM, et al. Neural complications and 
physical disabilities in leprosy in a capital of northeastern Brazil 
with high endemicity. Rev Bras Epidemiol. 2014;17:899-910. 
 17.  Brito AL, Monteiro LD, Ramos Júnior AN, Heukelbach J, Alencar 
CH.Temporal trends of leprosy in a Brazilian state capital in 
Northeast Brazil: epidemiology and analysis by joinpoints, 
2001 to 2012. Rev Bras Epidemiol. 2016;19:194-204. 
 18.  Cross H. The prevention of disability as a consequence of leprosy. 
Lepr Rev. 2015;86:208-12. 
 19.  Barbosa JC, Ramos Júnior AN, Alencar OM, Pinto MS, Casrro 
CG. Atenção pós-alta em hanseníase no Sistema Único de 
Saúde: aspectos relativos ao acesso na região Nordeste. Cad 
Saude Colet. 2014;22:351-8. 
 20.  Castro LE, Cunha AJ, Fontana AP, Castro Halfoun VL, Gomes 
MK. Physical disability and social participation in patients 
affected by leprosy after discontinuation of multidrug therapy. 
Lepr Rev. 2014;85:208-17.
 21.  Monteiro LD, Alencar CH, Barbosa JC, Novaes CC, Silva RC, 
Heukelbach J. Limited activity and social participation after 
hospital discharge from leprosy treatment in a hyperendemic 
area in north Brazil. Rev Bras Epidemiol. 2014;17:91-104. 
